Prescriber

NuvaRing: new combined hormonal contraceptive device

Authors

Steve Chaplin, Tina Peers

Abstract

NuvaRing is a new contraceptive device that delivers ethinylestradiol and etonogestrel and is inserted once every cycle for three weeks. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects and Dr Tina Peers comments on its place as a birth control option. Copyright © 2009 Wiley Interface Ltd

Digital Object Identifier (DOI)

10.1002/psb.526 About DOI

Bookmark and Share

Search the Site

Search

Therapeutics Plus

Learning Central

 ad block right